EUVIMEDEUVIMED entdecken
Crossref

Plasticity and Power: How MEIS Transcription Factors Define Melanoma Aggressiveness

Asya Kurtuluş

Gene Editing · 2026 · 1 (1) · 1-28

DOI: 10.29228/genediting.94090 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gene Editing, 2026. Verfasst von Asya Kurtuluş.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma is a highly aggressive malignancy characterized by significant phenotypic plasticity and the co-option of embryonic gene expression programs. Among the critical regulators of this process are the TALE-class homeobox transcription factors MEIS1, MEIS2, and MEIS3. These transcriptional assemblies act as central nodes that integrate hallmark oncogenic signaling pathways, such as the MAPK, PI3K/AKT, and TGF-beta axes, to drive tumor cell survival, proliferation, and invasiveness. The review further explores how MEIS factors influence the epigenetic landscape and phenotypic switching between differentiated and stem-like, dedifferentiated states. By orchestrating these developmental programs, MEIS1-3 proteins fundamentally reinforce the malignant identity of melanoma cells throughout the various stages of cancer progression.

Zitieren

APA

Kurtuluş, A. (2026). Plasticity and Power: How MEIS Transcription Factors Define Melanoma Aggressiveness. Gene Editing, 1(1), 1-28. https://doi.org/10.29228/genediting.94090

Vancouver

Kurtuluş A. Plasticity and Power: How MEIS Transcription Factors Define Melanoma Aggressiveness. Gene Editing. 2026;1(1):1-28. doi:10.29228/genediting.94090

BibTeX
@article{Kurtulu2026,
  author = {Kurtuluş, Asya},
  title = {Plasticity and Power: How MEIS Transcription Factors Define Melanoma Aggressiveness},
  journal = {Gene Editing},
  year = {2026},
  volume = {1},
  number = {1},
  pages = {1--28},
  doi = {10.29228/genediting.94090}
}
Kostenlos starten →